Menu
National List of Essential Medicines (NLEM)
- Ribociclib (จ2)/ Protocol Download/ Form
National Health Security Office Protocol (NHSO protocol)
- Bladder cancer & renal cell carcinoma Download
- Bone sarcoma Download
- Breast cancer Download
- Cervix cancer Download
- Pancreatobiliary cancer Download
- Colorectal cancer Download
- Esophageal cancer Download
- Head and neck cancer Download
- Lung cancer Download
- Ovarian cancer Download
- Prostate cancer Download
- Soft tissue sarcoma Download
- Stomach cancer Download
- Uterine cancer Download
- NHSO all protocol 2566 Download
- NHSO all protocol 2561 Download
- NHSO all protocol 2556 Download
Oncology Prior Authorization Protocol (OCPA protocol)
- Abiraterone 250 in Prostate cancer at 28/6/65 (ว693)
- Abiraterone in Prostate cancer at 28/6/65 (ว693)
- Aprepitant at 20/9/61 (ว424)
Protocol Download
- Atezolizumab (Abort) in NSCLC at 12/7/62 (ว340)
- Barthel ADL at 20/9/61 (ว424)
Protocol Download
- Bevacizumab in Colorectal cancer at 20/9/61 (ว424)
- Bevacizumab in Ovarian cancer at 20/9/61 (ว424)
- Brigatinib in NSCLC at 29/3/67 (ว185)
- Ceritinib in NSCLC at 29/3/67 (ว185)
- Crizotinib in NSCLC at 29/3/67 (ว185)
- Durvalumab in NSCLC at 9/10/67 (ว609)
- Enzalutamide in Prostate cancer at 28/6/65 (ว693)
- Erlotinib in NSCLC at 28/12/64 (ว1287)
- Gefitinib (Abort) in NSCLC at 28/12/64 (ว1287)
- Imatinib in DFSP at 27/10/65 (ว1342)
- Imatinib in GIST at 27/10/65 (ว1342)
- Lenvatinib in HCC at 26/1/66 (ว62)
- Lenvatinib in Thyroid cancer at 26/1/66 (ว62)
- Osimertinib in NSCLC at 28/12/64 (ว1287)
- Palbociclib in Breast cancer at 29/3/67 (ว185)
- Palonosetron at 20/9/61 (ว424)
Protocol Download
- Panitumumab in Colorectal cancer at 20/9/61 (ว424)
- Pazopanib in RCC at 20/9/61 (ว424)
- Pazopanib in Soft tissue sarcoma at 20/9/61 (ว424)
- Pembrolizumab in Melanoma cancer at 27/7/67 (ว375)
- Pembrolizumab in NSCLC cancer at 27/7/67 (ว375)
- Pertuzumab in Breast cancer at 27/10/65 (ว1342)
- Ribociclib (Abort) in Breast cancer at 12/7/62 (ว340)
- Sorafenib in HCC at 26/1/66 (ว62)
- Sorafenib in Thytoid cancer at 26/1/66 (ว62)
- Sunitinib in GIST at 19/1/61 (ว34)
- Trastuzumab in Breast cancer at 27/10/65 (ว1342)
- Trastuzumab in Stomach cancer at 27/10/65 (ว1342)
Oncology Prior Authorization Annoucement (OCPA annoucement)
- Annoucement ว609 9/10/67 Download (Durvalumab)
- Annoucement ว62 26/1/66 Download (Sorafenib, Lenvatinib)
- Annoucement ว1342 27/10/65 Download (Trastuzumab, Pertuzumab, Imatinib)
- Annoucement ว693 28/6/65 Download (Abiraterone, Enzalutamide)
- Annoucement ว1287 28/12/64 Download (Erlotinib, Osimertinib, Abort Gefitinib)
- Annoucement ว588 9/12/63 Download (Erlotinib; old)
- Annoucement ว278 19/6/63 Download (Trastuzumab; old, Pertuzumab; old)
- Annoucement ว532 12/11/62 Download (Trastuzumab; old)
- Annoucement ว340 12/7/62 Download (Atezolizumab; old, Ribociclib; old)
- Annoucement ว85 22/2/62 Download (Sorafenib; old, Osimertinib; old)
- Annoucement ว424 20/9/61 Download (Bevacizumab, Pazopanib, Ceritinib; old, Abiraterone; old, Enzalutamide; old, Panitumumab, Aprepitant, Palonosetron)
- Annoucement ว34 19/1/61 Download (Imatinib, Sunitinib, Trastuzumab; old, Gefitinib; old, Bevacizumab; old, drugs 22 items)
- Annoucement ว19 11/4/50 Download (Bevacizumab; old, Trastuzumab; old, Erlotinib; old, Gefitinib; old)
- Annoucement ว69 31/8/49 Download (Imatinib; old, Bevacizumab; old, Trastuzumab; old, Ertolinib; old, Gefitinib; old)
- Annoucement protocol 2549 Download (Imatinib; old, Bevacizumab; old, Trastuzumab; old, Ertolinib; old, Gefitinib; old)